Advertisement

Topics

Vanda Pharmaceuticals Inc. Company Profile

06:47 EDT 21st June 2018 | BioPortfolio


News Articles [506 Associated News Articles listed on BioPortfolio]

Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2017 Revenue Results and ...

Vanda expects to report 2017 total net product sales from HETLIOZ ®and Fanapt ®of approximately $165 million, consistent with Vanda's prior guidance Read more...

Vanda Pharmaceuticals’ Hetlioz Shows Promise for Treating Jet Lag

Vanda Pharmaceuticals announced positive results from its JET8 Phase III clinical trial of Hetlioz for jet lag disorder.

Vanda Pharmaceuticals nets $87.9mm in FOPO

Vanda Pharmaceuticals Inc. (specialty pharma) netted $87.9mm in a follow-on public offering of 5.5mm common shares at $17. The company plans to use the proceeds from the offering for commercial, rese...

Vanda Pharmaceuticals nets $87.6mm in FOPO

Vanda Pharmaceuticals Inc. (specialty pharma) netted $87.6mm in a follow-on public offering of 5.5mm common shares at $17. The company plans to use the proceeds from the offering for commercial, rese...

Insider Selling: Vanda Pharmaceuticals Inc. (VNDA) CFO Sells 9,155 Shares of Stock

Vanda Pharmaceuticals Inc. CFO James Patrick Kelly sold 9,155 shares of the stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $15.35, for a total value of ...

Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock

Vanda anticipates using the net proceeds from this offering for commercial, research and development activities and other general corporate purposes. The offering is expected to Read more...

Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q4 2017 Results - Earnings Call Transcript

Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q1 2018 Results - Earnings Call Transcript

Drugs and Medications [271 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [133 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Environmental concentrations of pharmaceuticals directly affect phytoplankton and effects propagate through trophic interactions.

Pharmaceuticals are found in freshwater ecosystems where even low concentrations in the range of ng Lmay affect aquatic organisms. In the current study, we investigated the effects of chronic exposure...

Clinical Trials [216 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1322 Associated Companies listed on BioPortfolio]

Vanda Pharmaceuticals

Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our comme...

Vanda Pharmaceuticals Inc.

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "Vanda Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Vanda Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Vanda Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Vanda Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vanda Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Vanda Pharmaceuticals Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record